Jump to content

David Saikin

Members
  • Posts

    2,989
  • Joined

  • Last visited

  • Days Won

    221
  • Country

    United States

Posts posted by David Saikin

  1. I think that your institution may develop whatever means they feel appropriate for emergency release.  The only caveat I have is that the MD who is  ordering is documented on the request.  Many times computer generated orders only have the attending who is in the system.  Definitely keep the phone call.

  2. Hi All

    Having a brain cramp or just getting old:  patients w sickle cell disease.  Do they always get Hgb S neg rbcs or only in crisis?  Can't find an answer in the books.

    Thanks ahead of time.

  3. 47 minutes ago, Baby Banker said:

    This is a long shot, but if your patient is black and transfused often, it could be ant-Jsa or anti-V/VS.  We see that not infrequently with our sickle cell patients who are on a chronic transfusion protocol. 

    It is a long shot.  I don't think I've ever seen a Jsa+ screening cell.

    Plus - it would be nice to know how strong the reaction(s) was and which cell(s) was reacting.

  4. 4 hours ago, bldbnkr said:

    I second this question - my trusty old Clay Adams just died and was deemed unrepairable.  Does anyone have a favorite since I have to purchase a brand new blood bank serofuge?

    Drucker says they used to make those for CA.  Their serofuge has a different body but the same rotor and guts.  FYI.

  5. On ‎03‎/‎10‎/‎2020 at 8:49 PM, Bbank90 said:

    Taking this case further...an alloadsorption was done, only one cell was positive when redoing the screen. C and E were then ruled out with a select cell. 
     

    If you have done the alloabsorption, do you not elute and test the absorbed abs?  I find it hard to believe that a patient would be sensitized to all the ags except C and E.  (The most abs I've ever encountered were 10).

  6. That's up to you and your Medical Director.  One thing to consider - that would be a lab developed test.  I thought I read a few years ago that the FDA was going to look at those (LDTs) - I think there was going to be a $250,000.00 fee (the initial fee for them to evaluate proposed new tests/drugs).  Also, when the Orthos and Immucors validate their antisera I believe they run considerably more than the "20" samples (including variants), so, while you may validate your process I don't believe your validation is as extensive, esp since you will be using reagent "off label".   I'd be more concerned with the LDT.  I'd check w the FDA to see their take on your proposal.  

    FYI - I've used gel off label for years w antigen typing (and a few other assorted tests).

×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.